Carl Langren
2016
In 2016, Carl Langren earned a total compensation of $842.8K as Vice President of Finance at NewLink Genetics, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $12,625 |
|---|---|
| Non-Equity Incentive Plan | $41,625 |
| Option Awards | $346,385 |
| Salary | $277,500 |
| Stock Awards | $148,089 |
| Other | $16,588 |
| Total | $842,812 |
Langren received $346.4K in option awards, accounting for 41% of the total pay in 2016.
Langren also received $12.6K in bonus, $41.6K in non-equity incentive plan, $277.5K in salary, $148.1K in stock awards and $16.6K in other compensation.
Rankings
In 2016, Carl Langren's compensation ranked 9,061st out of 14,075 executives tracked by ExecPay. In other words, Langren earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,061 out of 14,075 | 36th |
Division Manufacturing | 3,503 out of 5,486 | 36th |
Major group Chemicals And Allied Products | 1,201 out of 1,900 | 37th |
Industry group Drugs | 949 out of 1,543 | 39th |
Industry Pharmaceutical Preparations | 753 out of 1,173 | 36th |
Source: SEC filing on March 31, 2017.
Langren's colleagues
We found five more compensation records of executives who worked with Carl Langren at NewLink Genetics in 2016.
2016
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2016
Nicholas Vahanian
NewLink Genetics
Chief Medical Officer
2016
John Henneman
NewLink Genetics
Chief Financial Officer
2016
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2016
Eugene Kennedy
NewLink Genetics